Ozempic, Wegovy, and Mounjaro Allegedly Causing Severe Gastrointestinal Issues

Publish Date : 11/06/2024

Patients are filing lawsuits against the manufacturers of weight-loss drugs like Ozempic, Wegovy, and Mounjaro due to serious side effects, including gastroparesis (stomach paralysis), severe gastrointestinal issues, and other complications. One plaintiff, experienced extreme vomiting, significant weight loss, and a diagnosis of gastroparesis after taking Ozempic. Despite initial denials by doctors of a link to the medication, patients believe the drugs caused their health problems.

GLP-1 agonists, which include these drugs, are widely prescribed for diabetes and weight loss, yet side effects like nausea, vomiting, and digestive issues are common. Research suggests possible links between GLP-1 drugs and conditions such as gastroparesis, intestinal blockages, and even increased risk of thyroid tumors. Pharmaceutical companies Novo Nordisk and Eli Lilly, makers of these drugs, argue the side effects are generally mild and temporary, though ongoing lawsuits claim patients were not adequately warned of risks. A Pennsylvania judge is overseeing the cases, and more studies are expected to further clarify the long-term safety of these medications.